Clinical trial

Study Comparing Concomitant Docetaxel + Gemcitabine to Sequential Therapy of Docetaxel Followed by Gemcitabine

NCT00294385

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-06-01

PhasePHASE3

Study timeline

Study start (unknown)2002-06-01Date precision: month

Registry last updated2011-06-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

DocetaxelDRUG · verified · RxNorm: docetaxel

Gemcitabine, DocetaxelDRUG

DocetaxelDRUG · verified · RxNorm: docetaxel

Sponsors & collaborators

Central European Cooperative Oncology Grouplead sponsor

Mapped research locations

PragueCzechia2 SofiaBulgaria2 ViennaAustria1 KrakowPoland1 HaifaIsrael1 Tel AvivIsrael1 BrnoCzechia1 BratislavaSlovakia1 PlovdivBulgaria1 Hradec KrálovéCzechia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00294385 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.